Process for halohydrin preparation
    41.
    发明授权
    Process for halohydrin preparation 失效
    卤代醇制备方法

    公开(公告)号:US6162924A

    公开(公告)日:2000-12-19

    申请号:US290205

    申请日:1999-04-09

    申请人: Neil W. Boaz

    发明人: Neil W. Boaz

    CPC分类号: C07D307/20

    摘要: A process for preparing a halohydrin of a water-miscible olefin comprising: reacting a water-miscible olefin in water with a compound of the formula (I) ##STR1## wherein R.sub.1 and R.sub.2 independently represent a branched or unbranched, substituted or unsubstituted, lower alkyl having from 1 to 5 carbons and X is a halogen, to thereby form the halohydrin of the water-miscible olefin.

    摘要翻译: 一种制备水混溶性烯烃的卤代醇的方法,包括:使水中可与水混合的烯烃与水与式(I)化合物反应,其中R 1和R 2独立地表示支链或非支链的取代或未取代的低级烷基, 1至5个碳,X是卤素,从而形成水混溶性烯烃的卤代醇。

    Processing for washing-out degradation-resistant organic chlorine
compound
    42.
    发明授权
    Processing for washing-out degradation-resistant organic chlorine compound 失效
    洗涤降解有机氯化合物的加工

    公开(公告)号:US06018051A

    公开(公告)日:2000-01-25

    申请号:US91027

    申请日:1998-09-08

    CPC分类号: C10G21/006 B08B3/08

    摘要: In order to subject a cellulosic material such as insulating paper onto and into which transformer high-voltage insulating oil containing PCB has adhered and permeated to washing that removes the PCB etc. to an undetectable value, the cellulosic material to which PCB etc. has adhered is placed in DMI, sulfolane or other aprotic solvent containing an alkali such as caustic soda and stirred.

    摘要翻译: PCT No.PCT / JP97 / 03573 Sec。 371日期:1998年9月8日 102(e)1998年9月8日PCT PCT 1997年10月2日PCT公布。 公开号WO98 / 15361 日期1998年4月16日为了将诸如绝缘纸的纤维素材料放置在含有PCB的变压器的高压绝缘油附着并渗透到将PCB等去除的洗涤中,到达不可检测的值的纤维素材料, PCB等已经粘附在DMI,环丁砜或其它含碱如苛性钠的非质子溶剂中并搅拌。

    Imidazole derivatives as anti-HIV agents
    43.
    发明授权
    Imidazole derivatives as anti-HIV agents 失效
    咪唑衍生物作为抗HIV剂

    公开(公告)号:US5910506A

    公开(公告)日:1999-06-08

    申请号:US809624

    申请日:1997-05-30

    摘要: An imidazole derivative represented by general formula (I) or a salt thereof, having the effect of specifically inhibiting the growth of HIV as a pathogenic virus and being reduced in toxicity. In said formula R.sup.1 represents hydrogen, C.sub.1 -C.sub.20 alkyl, C.sub.2 -C.sub.7 alkenyl, C.sub.4 -C.sub.12 cycloalkylalkyl, etc.; R.sup.2 represents C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 acyl, hydroxyiminomethyl, hydrazonomethyl or --(CH.sub.2)n--R.sup.4 (R.sup.4 being halogeno, alkoxy, hydroxy, etc.; and n being an integer of 1 to 3); R.sup.3 represents substituted or unsubstituted C.sub.1 -C.sub.6 alkyl; X and Y represent each independently hydrogen, C.sub.1 -C.sub.3 alkyl, halogeno, or nitro; and Z represents S, SO, SO.sub.2 or CH.sub.2. ##STR1##

    摘要翻译: PCT No.PCT / JP95 / 01936 Sec。 371日期1997年5月30日 102(e)日期1997年5月30日PCT提交1995年9月25日PCT公布。 WO96 / 10019 PCT出版物 日期:1996年5月4日由通式(I)表示的咪唑衍生物或其盐,具有特异性抑制作为致病病毒的HIV生长且毒性降低的作用。 在所述式中,R 1表示氢,C 1 -C 20烷基,C 2 -C 7烯基,C 4 -C 12环烷基烷基等; R 2表示C 1 -C 6烷基,C 1 -C 6酰基,羟基亚氨基甲基,亚肼基甲基或 - (CH 2)n -R 4(R 4为卤代,烷氧基,羟基等; n为1至3的整数)。 R 3表示取代或未取代的C 1 -C 6烷基; X和Y各自独立地表示氢,C1-C3烷基,卤代或硝基; Z表示S,SO,SO 2或CH 2。

    Aminoheterocycle-substituted glycerols
    44.
    发明授权
    Aminoheterocycle-substituted glycerols 失效
    氨基杂环取代的甘油

    公开(公告)号:US5891881A

    公开(公告)日:1999-04-06

    申请号:US976408

    申请日:1997-11-21

    摘要: Aminoheterocycle-substituted glycerols of Formula I are disclosed: ##STR1## wherein one of A, B or C is --X--R, wherein X is --O-- or --S--, and R is a substituted or unsubstituted C.sub.12-24 alkyl or alkenyl, the substituent being one or more of halo, C.sub.1-3 alkoxy or cyano, provided that a double bond of the alkenyl does not originate at the carbon atom bound to X; and another of A, B or C is an aminoheterocycle ring substituent --Het--NH.sub.2, wherein Het is a 5 to 11-membered monocyclic, bicyclic or bicyclic fused heterocyclic ring moiety with at least 1 to 4 nitrogens atoms contained within the hetero cyclic moiety, one of which nitrogen atoms is bonded to the glycero carbon; and the remaining A, B, or C substituent is --OH. The compounds of Formula I, isomers, salts, pharmaceutical compositions and appliances incorporating the same, and methods of use thereof are also disclosed.

    摘要翻译: 公开了式I的氨基杂环取代的甘油:其中A,B或C中的一个为-XR,其中X为-O-或-S-,R为取代或未取代的C 12-24烷基或链烯基 所述取代基是卤素,C 1-3烷氧基或氰基中的一个或多个,条件是烯基的双键不是起始于与X结合的碳原子; A,B或C中的另一个是氨基杂环环取代基-Het-NH 2,其中Het是5至11元单环,双环或双环稠合杂环部分,其中杂环基部分内含有至少1至4个氮原子 其中氮原子之一与甘油碳键合; 其余的A,B或C取代基是-OH。 还公开了式I的化合物,异构体,盐,药物组合物和并入其的装置及其使用方法。